BioIntelliSense Announces FDA Clearance of the BioSticker™, the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring
An effortless patient experience combined with actionable clinical intelligence to bring medical-grade care to the home BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announces the U.S. commercial launch of its medical…